| 2024年中报 | 2023年年报 | 2022年年报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 抗肿瘤药(元) | 7,140,937,023.00 | 12,217,363,562.31 | 11,313,013,427.97 |
| 麻醉镇痛药(元) | 1,823,928,376.55 | 3,742,977,885.49 | 3,335,662,678.34 |
| 造影剂(元) | 1,374,776,264.86 | 2,742,422,889.85 | 2,728,731,268.44 |
| 其他(元) | 3,261,092,450.36 | 3,674,423,140.92 | 3,835,618,026.54 |
| 营业成本(元) | |||
| 抗肿瘤药(元) | 550,407,024.13 | 999,714,216.71 | 1,110,544,533.50 |
| 麻醉镇痛药(元) | 283,557,559.39 | 553,103,681.05 | 548,962,056.18 |
| 造影剂(元) | 534,138,608.28 | 1,065,618,930.30 | 940,828,460.27 |
| 其他(元) | 505,200,463.58 | 843,278,741.58 | 859,389,873.62 |
| 毛利(元) | |||
| 抗肿瘤药(元) | 6,590,529,998.87 | 11,217,649,345.60 | 10,202,468,894.47 |
| 麻醉镇痛药(元) | 1,540,370,817.16 | 3,189,874,204.44 | 2,786,700,622.16 |
| 造影剂(元) | 840,637,656.58 | 1,676,803,959.55 | 1,787,902,808.17 |
| 其他(元) | 2,755,891,986.78 | 2,831,144,399.34 | 2,976,228,152.92 |
| 毛利率(%) | |||
| 抗肿瘤药(%) | 92.29 | 91.82 | 90.18 |
| 麻醉镇痛药(%) | 84.45 | 85.22 | 83.54 |
| 造影剂(%) | 61.15 | 61.14 | 65.52 |
| 其他(%) | 84.51 | 77.05 | 77.59 |
| 收入构成(%) | |||
| 抗肿瘤药(%) | 52.50 | 54.60 | 53.33 |
| 麻醉镇痛药(%) | 13.41 | 16.73 | 15.72 |
| 造影剂(%) | 10.11 | 12.26 | 12.86 |
| 其他(%) | 23.98 | 16.42 | 18.08 |
| 毛利构成(%) | |||
| 抗肿瘤药(%) | 56.20 | 59.30 | 57.47 |
| 麻醉镇痛药(%) | 13.13 | 16.86 | 15.70 |
| 造影剂(%) | 7.17 | 8.86 | 10.07 |
| 其他(%) | 23.50 | 14.97 | 16.76 |